baber/WOPTO huggingface dataset:
Patent JP-2863465-B2 (JP)
IPC: B41J2/045
Filed: 1995-06-15
Granted: 1999-03-03
Abstract: A method of producing, on a physical medium, a gradient tonal representation of an image and a printhead for producing the same. An input image is divided into first and second regions. First, continuously variable intensity level, continuous tone and second, discretely variable intensity level, half-tone portions of the representation which respectively correspond to the first and second regions of the image are then printed by depositing selected quantities of ink on the first and second portions of the physical medium such that each pixel thereof has an ink intensity level corresponding to the image intensity level for the corresponding one of the pixels of the first region of the image. The ink is deposited on the second portion of the physical medium by depositing a spot of ink having a first diameter on selected ones of the pixels of the second portion, depositing a spot of ink having a second diameter on others of the pixels of the second portion and depositing no ink on still others of the pixels of the second portion such that the second portion of the representation has the desired ink intensity level. The color of the ink ejected may be black, in which case, the gradient tonal representation produced thereby shall be a gray scale representation, or other color such as yellow, cyan or magenta. <MATH>
Patent JP-2930380-B2 (JP)
IPC: A61P7/10
Filed: 1990-07-13
Granted: 1999-08-03
Abstract: A peptide composed of 53 amino acid residues represented by the following amino acid sequence: <IMAGE> and derivatives thereof represented by the following amino acid sequence: <IMAGE> wherein X is as shown in the specification, are disclosed. These polypeptides are novel and have natriuretic and hypotensive actions.
Patent JP-H088119-B2 (JP)
IPC: H01R13/658
Filed: 1986-08-27
Abstract: Cables (20) having interspersed co-planar signal and ground wires (22,24) in an insulating sheath (26) are terminated at a planar circuit board (40) by stripping back the insulation to expose the wires and by stapling the cable to the circuit board with a bus member (60). The signal wires (22) are soldered to signal wire termination sites (42) on the circuit board downstream from the bus member (60). The ground wires (24) are folded back over the bus member (60) and soldered thereto.
Patent JP-2988753-B2 (JP)
IPC: A01K67/027
Filed: 1991-08-28
Granted: 1999-12-13
Abstract: PURPOSE:To provide the method for establishing the new immortalized cell strain, capable of readily establishing the cell strain from the cells of the various organs of an identical animal and capable of accurately controlling the multiplication of the cell strain and the phenotypic expression of the differentiation of the cell strain, and further to provide the cell strain. CONSTITUTION:The method for establishing the immortalized cell strain is characterized by introducing a temperature-sensitive mutated SV40 large T antigen gene into the totipotent cell of a mammalian, collecting the tissue cells of the various organs of the gene-introduced animal, the cells being obtained by the normal production action of the animal, and subsequently subculturing the collected cells for the establishment of the cell strain. The immortalized cell strain multiplying at a culture temperature of 33-37 deg.C and established by the method is provided.
Patent JP-H0424570-B2 (JP)
IPC: F16B13/06
Filed: 1986-10-03
Abstract: A spreading anchor comprising an anchor rod (1) including a spreading cone (5) on its front end (4) in the direction of insertion of said anchor (1), the spreading cone (5) flaring in the insertion direction and adapted to cooperate with a spreading sleeve (9) which is provided with several longitudinal slots (10), said slots (10) originating from the front rim (11) of said spreading sleeve (9) and forming spreading lamellae (18), at least two of said spreading lamellae (18) being opposed, the end faces (21) of said opposed lamellae (18) in the insertion direction being provided with cutting inserts.
Patent JP-3192939-B2 (JP)
IPC: F04C18/02
Filed: 1995-08-31
Granted: 2001-07-30
Abstract: PROBLEM TO BE SOLVED: To provide a scroll type high performance fluid machine easy to be worked, with high strength in a scroll lap and a central part tip end, and capable of decreasing the innermost enveloped compression chamber volume to zero, without decreasing compressor efficiency. SOLUTION: A central part tip end shape 11 of a volute-shaped lap in each scroll is formed in at least two-step or more staircase shapes 11, 12, a central part tip end profile of the volute-shaped lap in each step is formed into a completely meshing profile joining loop/back side closed space in a meshing condition of both scrolls to decrease enclosed space capacity in the innermost envelope substantially to zero, and the staircase-shaped volute-shaped lap is formed by thinning a lap thickness in an upper step separating from an end plate.
Patent JP-2825780-B2 (JP)
IPC: C12Q1/68
Filed: 1995-09-01
Granted: 1998-11-18
Abstract: The invention provides a recombinant cDNA clone encoding cell surface receptor for laminin, as well as a probe and methods of using that probe to diagnose the aggressiveness of a carcinoma or the effectiveness of an agent for treating cancer cells.
Patent JP-3055049-B2 (JP)
IPC: A61B10/02
Filed: 1992-08-31
Granted: 2000-06-19
Abstract: An apparatus for the automated and facilitated handling and operation of a biopsy needle system (22), having a first inner needle (86) component and a second outer needle (96) component. The first inner (86) and second outer needles (96) are provided with first and second handles (88.98), respectively, which are fitted into first and second yokes (46,47) of the apparatus. The apparatus is configured to maintain the first inner (86) and second outer needles (96) in a first position, during insertion of the biopsy needle point into the tissue being sampled. The apparatus is further configured to move the first inner (86) and second outer needles (96) into second and third positions, respectively, in rapid, automated succession so as to segment and enclose a tissue sample, which may be tested after removal of the biopsy needle system from the tissue. A tissue sample inspection feature permits facilitated repositioning and maintenance of the first inner needle (86) relative to the second outer needle (96) after retrieval of the tissue sample to, in turn, enable inspection of the retrieved tissue sample without removal of either needle from the apparatus. <IMAGE>
Patent JP-3448471-B2 (JP)
IPC: F24F11/02
Filed: 1997-10-02
Granted: 2003-09-22
Abstract: PROBLEM TO BE SOLVED: To achieve accurate detection of human beings for efficient air conditioning. SOLUTION: Upon the ON operation of a power source switch of a sub remote control, a counter is reset/started. When an ON signal to be outputted from a human being detection sensor is inputted, the measurement of time t1 is started (step 122-step 216) while the ON signal is counted for the OFF time t2 exceeding fixed time (1 sec.) measuring the time t2 (step 218-step 236). When counts C are reached three times within a specified time (up to 10 sec.) (affirmative judgment at step 222), a human being is determined to be detected (step 238).
Patent JP-H026599-B2 (JP)
IPC: C02F5/12
Filed: 1985-12-04
Abstract: The scale-inhibiting agent used is a combination with a synergistic effect of at least 50% by weight of salified polymers of ethylenic acids, chosen from polymaleates, polyacrylates, polymethacrylates, maleateacrylate copolymers, acrylate-methacrylate copolymers, acrylate-methacrylate-itaconate terpolymers, and mixtures of these substances, and at most 50 wt. % aliphatic polyamines with the formula R-NH -(CH2)3]nNH2 wherein R represents an aliphatic radical having 12 to 18 carbon atoms and n can be an odd or even whole number between 1 and 6, the percentages being based on polymers and polyamines in the dry state. These percentages are preferably 5 to 15 wt. % aliphatic polyamines per 95 to 85 wt. % polymers.
Patent JP-2752666-B2 (JP)
IPC: B60C23/20
Filed: 1988-11-08
Granted: 1998-05-18
Abstract: In order to monitor gas leakage in the tires of a vehicle, absolute gas pressure and temperature in the tires are first simultaneously measured. A ratio of the measured pressure to the measured temperature for reach of the tires is then calculated. The calculated ratios are then compared to produce an indicator N and an alarm is issued when this indicator N deviates from a predetermined range of values.
Patent JP-2594780-B2 (JP)
IPC: C07D501/56
Filed: 1995-11-07
Granted: 1997-03-26
Abstract: New process for manufacturing cephtazidime pentahydrate having formula (III), characterized in that the ester group of the compound of formula (Ia) or an acid addition salt thereof is decomposed by using exclusively aqueous hydrochloric acid, and that the cephtazidime thus obtained is crystallized in the form of pentahydrate, directly from the reaction mixture by addition of bases or in that it is first isolated by the addition of acetone and/or ethanol or another water-soluble anti-solvent of cephtazidime dihydrochloride, and in that it is converted into pentahydrate by a method known per se.
Patent JP-2597372-B2 (JP)
IPC: A61K39/395
Filed: 1987-11-18
Granted: 1997-04-02
Abstract: Novel hybridoma cell lines producing monoclonal antibodies reactive with purified mucin antigens from normal and tumor sources are generated using mucins, including purified mucins from tumor sources. Epitopes on mucin antigens from normal and tumor sources are demonstrated to be distinct, using these new antibodies. The antibodies may be useful alone or in combination, in the diagnosis and treatment of cancer including malignancies of the breast and lung.
Patent JP-3197129-B2 (JP)
IPC: A61K31/381
Filed: 1993-12-22
Granted: 2001-08-13
Abstract: Use of a compound of formula (I): <CHEM>  wherein     n is 0, 1 or 2; R is hydroxyl, methoxy, C1-C7 alkanoyloxy, C3-C7 cycloalkanoyloxy, (C1-C6 alkoxy)-C1-C7 alkanoyloxy, substituted or unsubstituted aroyloxy, or substituted or unsubstituted aryloxycarbonyloxy; R<1> is hydrogen, hydroxyl, chloro, bromo, methoxy, C1-C7 alkanoyloxy, C3-C7 cycloalkanoyloxy, (C1-C6 alkoxy)-C1-C7 alkanoyloxy, substituted or unsubstituted or aroyloxy, or substituted or unsubstituted aryloxycarbonyloxy; R<2> is a heterocyclic ring selected from the group consisting of pyrrolidino, piperidino, or hexamethyleneimino; or a pharmaceutically acceptable salt or solvate thereof; in the preparation of a medicament useful for lowering serum cholesterol levels in animals.
Patent JP-3341211-B2 (JP)
IPC: B60L50/30
Filed: 1999-12-24
Granted: 2002-11-05
Abstract: PROBLEM TO BE SOLVED: To perform driving by means of stored electric power, by including a vehicle driving motor, an inverter driving the vehicle driving motor, a flywheel-type electric power storage system, a battery for driving the vehicle driving motor and the electric power storage system, and an electric power controller. SOLUTION: This electric vehicle is provided with a vehicle driving motor 30, an inverter 31 for converting direct current into alternating current for driving the motor 30, a flywheel-type electric power storage system 32, and an electric power controller 33 for controlling the inverter 31 and the electric power storage system 32. The power controller 33, provided with a battery for driving the vehicle driving motor 30 and the electric power storage system 32, is connected to an external charging power source 34. With the battery of the power controller 33 charged by the electric power supplied from the power source 34, a magnetic bearing controller 36 is driven by the battery, and the electric power controller 33 functions a motor 5 as a motor and drives the motor 5 through an inverter. It is thus possible to perform driving by means of stored electric power.
Patent JP-H0570897-B2 (JP)
Inventor: BERGER ENGELBERT
IPC: H01J35/02
Filed: 1986-03-13
Abstract: In order to increase the dielectrical resistance without resorting to internal shielding, the ring plate shaped ceramic insulators (13, 23) which carry the cathode (15) and the anode (25) at the axial inside end surfaces (16, 26) of the X-ray tube are stepped down in radial directions by a step (17, 27) in order to permit the forming of an axial hollow (18, 28) running in the form of a ring. On the ceramic insulator (13) which carries the cathode (15), the hollow (18) borders on the external periphery of the ceramic insulator. Conversely, the hollow (28) on the ceramic insulator (23) carrying the anode (25) borders on the inside periphery of the ceramic insulator. Each of the hollows is entirely filled with an insulation material (19, 29), the dielectric constant of which is less than that of the ceramic material. This insulation material (19, 29) is functionally part of a rubber-elastic ring plate (20, 30) which is pressed onto the outer axial end surface of the respective ceramic insulator (13, 23).
Patent JP-H0312120-B2 (JP)
IPC: C11D3/39
Filed: 1985-04-25
Abstract: A bleach product for use in the washing machine as an adjunct to a normal detergent powder or liquid comprises a closed bag containing a particulate bleach composition, the bag being formed of sheet material having pores large enough to render it water-permeable but small enough to confine the bleach composition within the bag. The bleach composition comprises sodium perborate with an activator : such as tetraacetyl ethylenebiamine or sodium octanoyloxybenzene sulphonate. Preferably at least 25 mole per cent of the perborate is in monohydrate form: this gives reduced malodour development on short storage.
Patent JP-H0817706-B2 (JP)
IPC: C12R1/18
Filed: 1986-08-01
Abstract: An enzyme for conversion of 2,5-diketo-D-gluconate (2,5-DKG) to 2-keto-L-gulonic acid (2-KLG) and a genetically modified organism that expresses all the fermentation enzymes needed to convert glucose to 2-KLG (a precursor to ascorbic acid) using the new enzyme. Preferably, the organism is Erwinia citreus, or a mutated strain of Erwinia citreus, unable to use 2,5-DKG or 2-KLG as a sole carbon source, into which the gene for a 2,5-DKG reductase, produced by Corynebacterium sp., SHS 752001, has been inserted. The preferred transformed organism expresses the fermentation enzymes Erwinia citreus normally expresses for fermentation of glucose to 2,5-DKG and, in addition, an enzyme Corynebacterium sp. SHS 752001 expresses for fermentation of 2,5-DKG to 2-KLG.
Patent JP-2927943-B2 (JP)
IPC: H01S3/06
Filed: 1990-03-08
Granted: 1999-07-28
Abstract: A laser amplifier having an improved pump efficiency for a given pump power comprises a pump source (46) longitudinally coupled at a plurality of coupling points (47, 48, 49) to an optical fibre (41). By thus coupling the pump power into the fibre (41), a fraction of the pump power is applied to the fibre (41) at each of the coupling points (47, 48, 49). A significant improvement in pump efficiency may be achieved in this way.
Patent JP-3435159-B2 (JP)
IPC: A01N63/50
Filed: 1993-07-12
Granted: 2003-08-11
Abstract: Four novel Bacillus thuringiensis strains, which are deposited at the BCCM-LMG under accession nos. LMG P-12592, LMG P-12593, LMG P-12594, and LMG P-13493, produce new crystal proteins during sporulation that are toxic to Lepidoptera, more particularly against Noctuidae such as Spodoptera spp. and Agrotis ipsilon, against Pyralidae such as Ostrinta nubilalis, and against Yponomeutidae such as Plutella xylostella, and that are encoded by a novel gene. The crystal proteins contain protoxins, which can yield a toxin as trypsin-digestion product. A plant, the genome of which is transformed with a DNA sequence that comes from either one of the strains and that encodes its respective toxin, is resistant to Lepidoptera. Each strain, itself, or its crystals, crystal proteins, protoxin or toxin can be used as the active ingredient in an insecticidal composition for combatting Lepidoptera.
Patent JP-3672569-B2 (JP)
IPC: A61F9/00
Filed: 1995-12-26
Granted: 2005-07-20
Abstract: Anti-inflammatory eyedrops comprising: (a)0.05 to 0.7 w/v % of diclofenac sodium; (b) 1 to 10 w/v % of  gamma -cyclodextrin; (c) 1 to 20 w/v % of polyvinylpyrrolidone; and (d) 0.002 to 0.01 w/v % of benzethonium chloride, or 0.002 to 0.005 w/v % of benzalkonium chloride; and having a pH value of 7.0 to 8.5. The eyedrops contain diclofenac sodium at a concentration over a wide range, remain stable for a long period of time, and little irritate the eyes.
Patent JP-4091658-B2 (JP)
IPC: A61K47/30
Filed: 1996-12-18
Granted: 2008-05-28
Abstract: Stabilized nanoparticles capable of being filtered under sterile conditions and including at least one hydrophobic, water-insoluble and non-water-dispersible polymer or copolymer (and optionally an active principle) emulsified in a solution of phospholipids and an oleic acid salt.
Patent JP-4327254-B2 (JP)
IPC: C30B33/00
Filed: 1997-12-15
Granted: 2009-09-09
Abstract: Atomic wires of great length and great stability are formed on the surface of a SiC substrate as straight chains of dimers of an element chosen from amongst SiC and C. In order to produce same, layers of the element are formed on the surface and the assembly is constructed by means of annealings of the surface provided with the layers. The resulting wires have application to nanoelectronics.
Patent JP-4318751-B2 (JP)
IPC: C12M1/34
Filed: 1997-03-12
Granted: 2009-08-26
Abstract: PCT No. PCT/GB97/00669 Sec. 371 Date Sep. 11, 1998 Sec. 102(e) Date Sep. 11, 1998 PCT Filed Mar. 12, 1997 PCT Pub. No. WO97/33973 PCT Pub. Date Sep. 18, 1997A process of culturing a microorganism in a culture medium in which process the addition of feed medium is controlled by using the production of a by-product as a measure of the culture conditions, characterized in that the by-product is an electrically charged metabolite produced by the microorganism, and in that the production of the metabolite is monitored by measuring the conductance of the culture medium. The metabolite may be acetate and the microorganism may be yeast which is genetically engineered to produce a desired polypeptide.
Patent JP-3948752-B2 (JP)
IPC: H04H20/88
Filed: 1997-04-02
Granted: 2007-07-25
Abstract: An apparatus for encoding a plurality of n digital information signals is provided with at least a first, second and third input terminal (1,2,3) for receiving a first, a second and a third digital information signal (L,R,C). A matrixing unit (10) is provided for generating a first and a second digital composite signal (L0,R0) from the at least the first, second and third digital information signals. First and second data compression means (22.1,22.2) are provided for data compressing the first and second composite signal (L0,R0) so as to obtain first and second data reduced digital composite signals. A first selection unit (16) is provided for selecting at least one information signal from said plurality of n information signals so as to obtain at least a first auxiliary signal (AUX1). At least a third data compression means (22.3) is present for data compressing the at least first auxiliary signal so as to obtain a first data reduced auxiliary signal. A formatting unit (24) is present for combining the first and second data reduced composite signals and the at least first data reduced auxiliary signal into a transmission signal suitable for transmission via a transmission medium. The apparatus further comprises at least first, second and third masked threshold determining means (26.1,26.3,26.4) for determining first (mtL), second (mtC) and third (mtL0) masked thresholds respectively. A second selection unit (28.1) is provided for deriving one masked threshold from at least the first (mtL) and third (mtL0) masked threshold so as to obtain a first selected masked threshold (mt1). Preferably, said first selected masked threshold is the smallest of the said at least first (mtL) and third (mtL0) masked thresholds.
Patent JP-3502640-B2 (JP)
IPC: A61L12/12
Filed: 1998-04-08
Granted: 2004-03-02
Abstract: Compositions, and methods for using such compositions, which are useful to destroy hydrogen peroxide in a liquid aqueous medium, such as that used to disinfect contact lenses. In one embodiment, the composition comprises a hydrogen peroxide destroying component effective when released in a hydrogen peroxide-containing liquid aqueous medium to destroy or cause the destruction of hydrogen peroxide present in the hydrogen peroxide-containing liquid aqueous medium, and a barrier component acting to substantially prevent the release of the hydrogen peroxide destroying component for a period of time after the composition is initially contacted with the hydrogen peroxide-containing liquid aqueous medium, the barrier component comprising a material selected from the group consisting of water soluble cellulose derivatives and mixtures thereof having a molecular weight of at least about 20,000. The composition results in reduced foam formation relative to a similar composition including a barrier component comprising a similar material having a molecular weight of 10,000 when both the composition and the similar composition are exposed to identical hydrogen peroxide-containing liquid aqueous media to destroy or cause the destruction of the hydrogen peroxide therein.
Patent JP-4359344-B2 (JP)
IPC: C08J7/12
Filed: 1998-03-25
Granted: 2009-11-04
Abstract: Methods for producing by electrochemical reduction a carbon-containing material with its surface modified by organic groups, in particular functionalized organic groups. Certain embodiments of the methods include contacting the carbon-containing material with an organic diazonium salt in solvent, optionally in the presence of an electrolyte and negatively polarizing the carbon-containing material relative to an anode also in contact with an electrolytic solution separate from said diazonium salt solution, wherein the electrochemical reduction is carried out on an organic diazonium salt in protic solvent in an acid medium. Carbon-containing materials with a surface modified by organic groups and the use of these modified materials, for example for producing composite materials or for fixing molecules of biological interest, are taught.
Patent JP-4138895-B2 (JP)
IPC: G01N21/64
Filed: 1998-01-29
Granted: 2008-08-27
Abstract: A sample substrate (51, Fig. 4A) for use in a fluorescence imaging system (Fig. I) includes a rigid base with a specularly reflective surface, typically metal, on which is deposited a transparent coating layer (53). The coating layer has a thickness selected so that a particular fluorescence excitation wavelength, corresponding to a specified fluorescent constituent to besought in sample material, has an optical path from the top of the coating layer to the reflecting surface in the base of substantially an odd multiple of one-quarter wavelength, so that the standing wave of the fluorescence excitation wavelength of light incident of the substrate has an antinode (61) located at or near where sample material would be disposed on top of the coating layer. This maximizes fluorescence excitation of the sample on the reflective substrate. The transparent coating layer may be a dielectric material (e.g. silica) or may be a multilayer structure with a top layer of biologically active material for binding a specified sample constituent.